Published in Best Pract Res Clin Haematol on October 15, 2013
Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation. Chromosome Res (2015) 0.82
Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia. Onco Targets Ther (2016) 0.76
CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome. Oncotarget (2016) 0.75
Correlation between p65 and TNF-α in patients with acute myelocytic leukemia. Oncol Lett (2015) 0.75
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Mutation in TET2 in myeloid cancers. N Engl J Med (2009) 16.07
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell (2010) 13.13
Frequent pathway mutations of splicing machinery in myelodysplasia. Nature (2011) 11.44
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med (2004) 9.81
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood (2009) 5.72
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol (2010) 5.62
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol (2009) 4.18
Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med (2012) 4.05
Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia (2012) 1.64